JOURNAL OF PATHOLOGY 期刊简介
The Journal of Pathology aims to serve as a translational bridge between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The main interests of the Journal lie in publishing studies that further our understanding the pathophysiological and pathogenetic mechanisms of human disease.
The Journal welcomes investigative studies on human tissues, in vitro and in vivo experimental studies, and investigations based on animal models with a clear relevance to human disease, including transgenic systems. In general, hypothesis driven studies that appropriately employ multiple investigative techniques are preferred over those that rely on a single methodology.
As well as original research papers, the Journal seeks to provide rapid publication in a variety of other formats, including editorials, review articles, commentaries and perspectives and other features, both contributed and solicited.
Purely descriptive papers on diagnostic pathology (including case reports and prognostic papers without mechanistic and experimental insights) are not considered central to the Journal’s purpose. Correspondence relating to papers published in the Journal will be considered, but only if of general interest. Such correspondance may be published in online versions only, at the Editor's discretion.
In determining content, the primary considerations are excellence, relevance and novelty. As the journal of The Pathological Society, it seeks to reflect the broad scientific interests of the Society’s membership but its ethos, authorship, content and purpose are those expected of a leading publication in the international scientific literature.
病理学杂志旨在作为基础生物医学科学和临床医学之间的转化桥梁,特别强调但不限于基于组织的研究。该杂志的主要兴趣在于发表研究,进一步了解人类疾病的病理生理和致病机制。
该杂志欢迎对人体组织的调查研究,体外和体内实验研究,以及基于与人类疾病明确相关的动物模型的调查,包括转基因系统。一般来说,假设驱动的研究适当地采用了多种调查技术,而不是那些依赖于单一方法的研究。
除了原创研究论文,该期刊试图以各种其他格式提供快速出版,包括社论,评论文章,评论和观点以及其他功能,
关于诊断病理学的纯描述性论文 (包括没有机械和实验见解的病例报告和预后论文) 都不被认为是该杂志目的的核心。将考虑与期刊上发表的论文有关的信件,但前提是要引起普遍关注。这种对应关系只能在在线版本中发布,由编辑自行决定。
在确定内容时,主要考虑因素是卓越,相关性和新颖性。作为《病理学学会杂志》,它旨在反映该学会成员的广泛科学利益,但其精神,作者身份,内容和目的是国际科学文献中领先出版物所期望的。
期刊ISSN
|
0022-3417 |
影响指数
|
7.916 |
最新CiteScore值
|
11.80 查看CiteScore评价数据 |
最新自引率
|
1.50% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ |
偏重的研究方向(学科)
|
医学-病理学 |
出版周期
|
Monthly |
出版年份
|
1969 |
出版国家/地区
|
ENGLAND |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
ONCOLOGY(肿瘤学)2区
PATHOLOGY(病理学)1区
否
|
|||||
最新的影响因子
|
7.916 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 168 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
11.80
|
||||||||||
年文章数 | 152 | ||||||||||
SJR
|
2.964 | ||||||||||
SNIP
|
1.754 | ||||||||||
CiteScore排名
|
|
||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
INTEGRATIVE CANCER THERAPIES | 3.246 |
Hormones & Cancer | 3.83 |
ENDOCRINE-RELATED CANCER | 5.621 |
Frontiers of Medicine | 4.546 |
Molecular Medicine Reports | 2.922 |
Molecular Therapy-Oncolytics | 7.128 |
American Journal of Translational Research | 4.019 |
BREAST | 4.336 |
Breast Care | 2.831 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
ENDOCRINE-RELATED CANCER | 5.621 |
Molecular Therapy-Oncolytics | 7.128 |
GYNECOLOGIC ONCOLOGY | 5.427 |
ORAL ONCOLOGY | 5.284 |
MOLECULAR CARCINOGENESIS | 4.736 |
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 10.573 |
STEM CELLS | 6.214 |
CANCER GENE THERAPY | 5.927 |
EJSO | 4.38 |
分享者 | 点评内容 |